Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009-Reference-Cited by-同舟云学术

Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009

Published:2012-01 Issue:1 Volume:27 Page:70-75
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol Clin Exp

Author:

Yoshio Takashi¹²³,Inada Toshiya⁴,Uno Junji⁵,Miwa Takaichi⁶,Kitagawa Kohei⁷,Miyahara Yoshiki⁸,Umeda Kenta⁹,Kato Tsuyoshi¹⁰,Inagaki Ataru¹¹,Nabeshima Toshitaka²³

Affiliation:

1. Clinical Pharmacy, Faculty of Pharmaceutical Sciences; Toho University; Funabashi Japan

2. Department of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences; Meijo University; Nagoya Japan

3. Japanese Drug Organization for Appropriate Use and Research; Nagoya Japan

4. Seiwa Hospital; Institute of Neuropsychiatry; Tokyo Japan

5. Department of Pharmacy; Okehazama Hospital Fujita Kokoro Care Center; Toyoake Japan

6. Department of Pharmacy; Yuge Hospital; Kumamoto Japan

7. Department of Pharmacy; Okayama University Hospital; Okayama Japan

8. Department of Pharmacy; Osaka General Medical Center; Osaka Japan

9. Division of Pharmacy; Souseikai-Matsuyama Kinen Hospital; Matsuyama Japan

10. Department of Pharmacy; Tokorozawa Jikou Hospital; Tokorozawa Japan

11. Graduate School of Health Management; Keio University; Fujisawa Japan

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology,Neurology

Reference25 articles.

1. Prescribing for inpatients with schizophrenia: an international multi-center comparative study;Bitter;Pharmacopsychiatry,2003

2. Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change;Chong;Psychiatr Clin Neurosci,2004

3. Management of neuroleptic-induced movement disorders: effects of physician training;Dixon;Am J Psychiatry,1989

4. D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotics;Farde;Arch Gen Psychiatry,1988

5. Antipsychotic polypharmacy or monotherapy?;Gardos;Neuropsychopharmacol Hung,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics;Frontiers in Psychiatry;2022-05-17

2. Subthreshold Change in Glycated Hemoglobin and Body Mass Index After the Initiation of Second-Generation Antipsychotics Among Patients With Schizophrenia or Bipolar Disorder;The Journal of Clinical Psychiatry;2022-03-30

3. Trends in Prescribing Antipsychotics for Children and Adolescents in Japan: A Descriptive Epidemiological Study Using a Large-Scale Pharmacy Dataset;Child Psychiatry & Human Development;2022-02-24

4. Japanese Society of Neuropsychopharmacology: “Guideline for Pharmacological Therapy of Schizophrenia”;Neuropsychopharmacology Reports;2021-08-12

5. Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients;Journal of Clinical Psychopharmacology;2021-06-08